Northern Technologies International Corporation Common Stock (NTIC)
CyclicalFairStock Score: 38/100 — MIXED
Key Financials
| Current Price | $7.71 |
| Market Cap | $73M |
| P/E Ratio | -59.31 |
| ROE | -0.1% |
| Dividend Yield | 0.53% |
| Sector | Basic Materials |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look for businesses with durable competitive advantages, consistent earning power, and a margin of safety. Northern Technologies is a small specialty chemicals firm—269 employees—selling rust and corrosion inhibitors, mostly under ZERUST, plus Natur-Tec. The niche is understandable, but the numbers do not yet show a moat. In fiscal Q3 2026, the quarter ended 2026-05-31, revenue was $24.2M but net income was -$263,291 and diluted EPS -$0.03. Fiscal Q2 2026 had revenue of $22.0M and a net loss of $35,323. Fiscal Q1 2026 did produce $237,819 of net income on $23.3M revenue, but the trend is fragile. For FY2025, revenue was $84.2M and net income only $17,619; FY2024 had $85.1M revenue and $5.4M net income. So sales are not collapsing—Q3 2026 revenue exceeded Q3 2025's $21.5M—but profits have collapsed. FairStock shows a negative P/E of -59.23 and P/B of 1.00 at the 2026-10-13 close of $7.70. The balance sheet is a relative bright spot with D/E of 0.20, but trailing free cash flow is -$3.9M, a -5.4% FCF yield, and ROE is -0.10%. The Piotroski F-Score of 3/9 and Altman Z-Score of 2.54 suggest financial quality is weak. EV/EBITDA of 17.96 is not a bargain for a cyclical specialty chemical company with erratic earnings. The Lynch category is CYCLICAL, and cyclicals can recover, but I see no margin of safety yet. I would want evidence of durable positive earnings and cash generation before calling this a sound value.
In plain English: Northern Technologies sells rust and corrosion prevention products, mainly under the ZERUST brand, and also has a Natur-Tec business. It is currently unprofitable, with a small loss in the latest reported quarter and very weak full-year profit, so the business looks weak. At $7.70, the price is close to its accounting value and below its 52-week high, but with no real earnings and negative cash flow it does not look clearly cheap.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q3 2026 10-Q (period ended 2026-05-31) · fiscal Q2 2026 10-Q (period ended 2026-02-28) · fiscal Q1 2026 10-Q (period ended 2025-11-30) · fiscal Q3 2025 10-Q (period ended 2025-05-31) · FY2025 10-K (period ended 2025-08-31) · FY2024 10-K (period ended 2024-08-31) · FY2023 10-K (period ended 2023-08-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer